Long-Term Changes in Submacular Choroidal Thickness after Intravitreal Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration: 14-Mo Follow-Up

Curr Eye Res. 2020 Apr;45(4):527-528. doi: 10.1080/02713683.2019.1675174. Epub 2019 Oct 3.

Authors

Sibel Inan¹, Zeki Baysal², Umit Ubeyt Inan³

Affiliations

¹ Department of Ophthalmology, Health Sciences University Medical School, Afyonkarahisar, Turkey.
² Department of Ophthalmology, Batman State Hospital, Batman, Turkey.
³ Department of Ophthalmology, Parkhayat Hospital, Afyonkarahisar, Turkey.

PMID: 31581852
DOI: 10.1080/02713683.2019.1675174

No abstract available

Keywords: Choroidal thickness; diurnal variation; neovascular age-related macular degeneration; ranibizumab; topographic variation.

Publication types

Letter
Comment

MeSH terms

Choroid*
Follow-Up Studies
Humans
Intravitreal Injections
Macular Degeneration*
Ranibizumab

Substances

Ranibizumab